Infant Nutrition Disorders: Clinical Trials

2 trials for Infant Nutrition Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 11Terminated 1
Phase 31Completed 1

Follow Infant Nutrition Disorders: new trials by email Literature Review of Infant Nutrition Disorders trials Research Report on Infant Nutrition Disorders

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome
Phase 1 / Phase 2TerminatedAlberta Children's Hospital132012-01-012014-12-23
Vitamin D Supplementation in Breastfeeding Women
Vitamin D3 - Vitamin D Deficiency, Rickets
Phase 2 / Phase 3CompletedMayo Clinic802010-12-012013-04-30

Narrower conditions

Enterocolitis, Necrotizing (1)  ·  Gastroschisis (1)  ·  Intestinal Atresia (1)  ·  Intestinal Failure (1)  ·  Malnutrition (1)  ·  Rickets (1)  ·  Short Bowel Syndrome (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Musculoskeletal Diseases (2)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Avitaminosis (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Calcium Metabolism Disorders (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Deficiency Diseases (1)  ·  Digestive System Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Enterocolitis (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)

Interventions

Cholecalciferol (1)  ·  Glucagon-Like Peptide 2 (1)

Sponsors

Alberta Children's Hospital (1)  ·  Mayo Clinic (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

David Sigalet, MD PhD (1)  ·  Thomas Thacher, MD (1)

Results publications

PMID 24290111, PMID 29486367